Cutting edge: A monoclonal antibody specific for the programmed death-1 homolog prevents graft-versus-host disease in mouse models

Journal of Immunology

Volumn 187, Issue 4, 2011, Pages 1537-1541

  Flies, Dallas B ^a   Wang, Shengdian ^b   Xu, Haiying ^c   Chen, Lieping ^a,d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUTE OF BIOPHYSICS   (China)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d YALE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY MH5A; PROGRAMMED DEATH 1 HOMOLOG; PROGRAMMED DEATH 1 RECEPTOR; UNCLASSIFIED DRUG;

ACUTE GRAFT VERSUS HOST DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SURFACE; CHIMERA; CONTROLLED STUDY; GENE EXPRESSION; HEMATOPOIETIC CELL; IMMUNOMODULATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIGENS, SURFACE; APOPTOSIS REGULATORY PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MICE; TRANSPLANTATION, HOMOLOGOUS;

EID: 80051930238     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1100660     Document Type: Article

References (17)

1. Wang, S., and L. Chen. 2004. T lymphocyte co-signaling pathways of the B7-CD28 family. Cell. Mol. Immunol. 1: 37-42.
2. Greenwald, R. J., G. J. Freeman, and A. H. Sharpe. 2005. The B7 family revisited. Annu. Rev. Immunol. 23: 515-548. (Pubitemid 40563179)
3. Linsley, P. S., E. A. Clark, and J. A. Ledbetter. 1990. T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc. Natl. Acad. Sci. USA 87: 5031-5035.
4. Linsley, P. S., W. Brady, M. Urnes, L. S. Grosmaire, N. K. Damle, and J. A. Ledbetter. 1991. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174: 561-569.
5. Wang, S., G. Zhu, A. I. Chapoval, H. Dong, K. Tamada, J. Ni, and L. Chen. 2000. Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS. Blood 96: 2808-2813.
6. Keir, M. E., M. J. Butte, G. J. Freeman, and A. H. Sharpe. 2008. PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 26: 677-704. (Pubitemid 351600389)
7. Sedy, J. R., M. Gavrieli, K. G. Potter, M. A. Hurchla, R. C. Lindsley, K. Hildner, S. Scheu, K. Pfeffer, C. F. Ware, T. L. Murphy, and K. M. Murphy. 2005. B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Nat. Immunol. 6: 90-98. (Pubitemid 40136700)
8. Kuipers, H., F. Muskens, M. Willart, D. Hijdra, F. B. Van Assema, A. J. Coyle, H. C. Hoogsteden, and B. N. Lambrecht. 2006. Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation. Eur. J. Immunol. 36: 2472-2482. (Pubitemid 44420603)
9. Cai, G., and G. J. Freeman. 2009. The CD160, BTLA, LIGHT/HVEM pathway: A bidirectional switch regulating T-cell activation. Immunol. Rev. 229: 244-258.
10. Mueller, D. L. 2010. Mechanisms maintaining peripheral tolerance. Nat. Immunol. 11: 21-27.
11. Tanaka, J., M. Asaka, and M. Imamura. 2000. T-cell co-signalling molecules in graft-versus-host disease. Ann. Hematol. 79: 283-290. (Pubitemid 30349018)
12. Socié, G., and B. R. Blazar. 2009. Acute graft-versus-host disease: From the bench to the bedside. Blood 114: 4327-4336.
13. Ogasawara, K., S. K. Yoshinaga, and L. L. Lanier. 2002. Inducible costimulator costimulates cytotoxic activity and IFN-gamma production in activated murine NK cells. J. Immunol. 169: 3676-3685.
14. Paczesny, S., S. W. Choi, and J. L. Ferrara. 2009. Acute graft-versus-host disease: New treatment strategies. Curr. Opin. Hematol. 16: 427-436.
15. Wilcox, R. A., D. B. Flies, G. Zhu, A. J. Johnson, K. Tamada, A. I. Chapoval, S. E. Strome, L. R. Pease, and L. Chen. 2002. Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors. J. Clin. Invest. 109: 651-659. (Pubitemid 34204844)
16. Khaled, Y., P. Reddy, and O. Krijanovski. 2009. Emerging drugs for acute graftversus- host disease. Expert Opin. Emerg. Drugs 14: 219-232.
17. Wang, L., R. Rubinstein, J. L. Lines, A. Wasiuk, C. Ahonen, Y. Guo, L. F. Lu, D. Gondek, Y.Wang, R. A. Fava, et al. 2011. VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses. J. Exp. Med. 208: 577-592.